Outlook of Diabetic Macular Edema – Current Landscape and the Way ForwardLONG-LASTING VEGF BLOCKERS, COMPOUNDS WITH VEGF- INDEPENDENT MECHANISM AND, TOPICAL AND ORAL TREATMENT OPTIONS, BRING THE QUEST FOR THE “IDEAL RETINAL DRUG” A STEP CLOSER�

SKU ID : MP-15927290 | Publishing Date : 03-Jul-2020 | No. of pages : 81

Detailed TOC of Outlook of Diabetic Macular Edema – Current Landscape and the Way ForwardLONG-LASTING VEGF BLOCKERS, COMPOUNDS WITH VEGF- INDEPENDENT MECHANISM AND, TOPICAL AND ORAL TREATMENT OPTIONS, BRING THE QUEST FOR THE “IDEAL RETINAL DRUG” A STEP CLOSER�

Table 1: NOVEL DME THERAPIES IN DEVELOPMENT AND UPCOMING  
               DEVELOPMENT  MILESTONES
Table 2: TREATMENT OF DIABETIC MACULAR EDEMA IN THE US
Table 3: STUDIES OF ANTI-VEGF AGENTS AND CHANGE IN BCVA IN DME 
               PATIENTS 
Table 4: STUDIES OF STERIOD AGENTS AND CHANGE IN BCVA IN DME 
               PATIENTS
Table 5: NEW TRIAMCINOLONE ACETONIDE (MAQAID) DETAILS
Table 6: INDIRECT COMAPRISON OF MAQAID WITH OTHER OPHTHALMIC
                STERIODS FOR DME
Table 7: NOVEL DME THERAPIES IN DEVELOPMENT
Table 8: DME PIPELINE -PHASE III
Table 9: DME PIPELINE -PHASE II
Table 10: DME PIPELINE -PHASE I
Table 11: DME PIPELINE -PRE-CLINICAL

List of Figures, Tables and Charts Available in Outlook of Diabetic Macular Edema – Current Landscape and the Way ForwardLONG-LASTING VEGF BLOCKERS, COMPOUNDS WITH VEGF- INDEPENDENT MECHANISM AND, TOPICAL AND ORAL TREATMENT OPTIONS, BRING THE QUEST FOR THE “IDEAL RETINAL DRUG” A STEP CLOSER�

Figures 1: PROGRESSION OF DME
Figures 2: PATHOLOGY OF DME VISIBLE ON OCT IMAGING
Chart 1: NUMBER OF DME TREATED PATIENTS IN THE US (2014-2019)
Chart 2: US DME THERAPEUTIC MARKET SIZE IN 2019 AND 2025
Chart 3: US ANTI-VEGF THERAPEUTIC MARKET SIZE, 2014-2019
Chart 4: VALUE AND VOLUME SHARES OF CURRENT OPHTHALMIC ANTI-
              VEGF’S IN THE   US
Chart 5: US DME ANTI-VEGF THERAPEUTIC MARKET SIZE – 2019
Chart 6: US DME ANTI-VEGF THERAPEUTIC MARKET SIZE, 2020-2025
Chart 7: US DME-ANTI-VEGF OPHTHALMIC VALUE MARKET SHARE IN 2025
Chart 8: US STERIOD OPHTHALMIC MARKET SIZE BY VALUE, 2014-2019
Chart 9: US STERIOD OPHTHALMIC MARKET SIZE BY VOLUME, 2014-2019
Chart 10: US DME STERIODS THERAPEUTIC MARKET SIZE IN 2019 AND IN  
                 2025

PRICE
4500
9500


  • market Reports market Reports